Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.75 (1.66%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £42.17m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Patent Update

7 Mar 2005 13:46

FOR IMMEDIATE RELEASE 7 March 2005 Timestrip Plc ("Timestrip" or the "Company") Timestrip Plc Announces Progress on European and South African Patents The Board of Timestrip plc, which markets an inexpensive and versatiletechnology for accurately measuring lapsed time, is pleased to announce that ithas received advance notification from the European Patent office of itsintention to grant a European Patent for its Timestrip technology andmanufacturing process (application number 02 743 427.3.). The Company is alsopleased to announce that a corresponding patent application has now beengranted in the Republic of South Africa. Further Patents are being pursued in major jurisdictions across the world andthe Company is confident of reporting further progress in securing approvals inthe coming months. Timestrip currently supplies customers both in the US and UK in the FoodService markets and is progressing with its existing development contracts forintegration of the technology into devices and packaging. Expiry dates featureprominently in five international mass markets and represent significantopportunities for Timestrip's technology. The key markets are: Food Retailing;Catering and Food Services; Consumables; Pharmaceuticals and Medical Devices. Paul Freedman, Joint CEO of Timestrip plc commented: "Timestrip's technology has significant applications in a number ofinternational mass markets and therefore it is crucial for the group to securethe underlying Patents to our technology and manufacturing processes. We arevery pleased that good progress has been made in this area in tandem withfurther progress on the integration\development front and we look forward tomaking further announcements in due course" For further information: Paul Freedman, Joint CEO and founding Director, Timestrip 01462 440700Stephen Oakes, Falcon Securities 0207 375 1177Shane Dolan,Biddicks 0207448 1000Roland Cornish, Beaumont Cornish Limited 0207 628 3396END
Date   Source Headline
15th Nov 202312:54 pmRNSChange of Nominated Adviser & Corporate Broker
9th Nov 20237:00 amRNSTrading Update
7th Nov 202311:45 amRNSResult of AGM
23rd Oct 20238:30 amRNSDirector Share Purchase
19th Oct 20237:00 amRNSDirector Share Purchase
11th Oct 20237:00 amRNSDirector Share Purchases
3rd Oct 20237:00 amRNSDirector/PDMR Shareholdings: Vesting of Options
27th Sep 20238:30 amRNSNotice of AGM
26th Sep 20237:00 amRNSQ1 Trading Update
26th Sep 20237:00 amRNSFinal Results
19th Sep 20237:00 amRNSAppointment of Independent Non-Executive Directors
12th Sep 20237:00 amRNSOwn-Book Update, Notice of Results, Pres & AGM
11th Jul 20237:00 amRNSDirector Share Purchase
29th Jun 20237:00 amRNSFull Year Trading Update
24th May 20239:04 amRNSDelivery of First Asset-Based Lending Facility
3rd May 20237:00 amRNSTrading Update & Notice of Final Results
8th Mar 20237:00 amRNSQ3 Trading Update: Pre-Tax Profits up 172%
9th Feb 202311:40 amRNSHolding in Company
26th Jan 202311:05 amRNSSecond Price Monitoring Extn
26th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSInterim Results
20th Dec 20221:24 pmRNSExercise of Options & Director/PDMR Shareholding
16th Dec 20227:00 amRNSH1 Trading Update & Notice of Interim Results
14th Nov 20227:00 amRNSDirector Share Purchases
3rd Nov 20227:00 amRNSMelloLondon Investor Conference
31st Oct 20222:00 pmRNSResult of AGM
19th Oct 20227:00 amRNSOwn Book Lending Portfolio reaches record £145m
5th Oct 20227:00 amRNSDirector Share Purchase
4th Oct 202212:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20222:15 pmRNSNotice of AGM
22nd Sep 20227:00 amRNSQ1 Trading Update
22nd Sep 20227:00 amRNSFinal Results for the year ended 31 May 2022
15th Sep 20227:00 amRNSNotice of Results & Q1 Update and Presentation
6th Sep 20227:00 amRNSAppointments Strengthen Asset Finance Division
22nd Jul 20227:00 amRNSNew LTIP & Director/PDMR Shareholding
19th Jul 20227:02 amRNSDirector Share Purchases
18th Jul 20227:00 amRNSDirector Share Purchase
7th Jul 20227:00 amRNSTrading Update & Notice of Final Results
10th Jun 20227:00 amRNSNotice of Trading Update and Investor Presentation
5th May 20229:19 amRNSHolding in Company
27th Apr 20223:28 pmRNSHolding in Company
27th Apr 202212:51 pmRNSHolding in Company
26th Apr 20223:30 pmRNSTR-1 Holding in Company
26th Apr 20229:36 amRNSTR-1 Holding in Company
14th Feb 202210:00 amRNSExercise of Options & Director/PDMR Shareholdings
20th Jan 20227:00 amRNSInterim Results
5th Jan 20227:00 amRNSNotice of Interim Results Investor Presentation
15th Dec 20217:00 amRNSH1 Trading Update & Notice of Interim Results
21st Oct 20213:40 pmRNSResult of AGM & Directorate Change
1st Oct 20217:00 amRNSVesting of Share Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.